… An economic analysis showed that the costs associated with GWs in men and females
represented 24.3% (€70.9 million) of the total costs associated with HPV6/11/16/18 diseases in …

… assessing the cost-effectiveness of HPV vaccination as costs of the program are incurred
at the moment of vaccination while benefits can occur in the short (genital warts) to long term (…

… anogenital wart diagnoses from a diagnosis of condyloma acuminata, or either a less specific
viral wart diagnosis or genital wart medication combined with either a benign anogenital …

… findings (eg, pearly penile papules) can mimic genital warts. The performance of physical …
in this review although it will impact the practice of all physicians who treat genital warts in …

… In the last years it emerged that in Italy the anogenital warts were more frequent (40,871 …
) and genital herpes (7860 cases, 7.6% of the total). In particular the anogenital warts were the …

… The majority of STIs were genital warts which, owing to their visible and symptomatic
nature, are likely to have a greater QALY decrement than STIs that can be present with no …

… Between 500,000 and 1 million new cases of genital warts … for genital warts. A high number
occurs in the later teenaged and early college-aged population. Genital warts, like most warts…

… Randomized controlled trial and economic evaluation of podophyllotoxin solution,
podophyllotoxin cream and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:…

… genital warts and recurrent respiratory papillomatis. In the context of the arrival of a nonavalent
HPV vaccine (6/11/16/18/31/33/45/52/58), this analysis … the existing economic evaluation …

… Only the 4-valent and 9-valent vaccines are indicated to prevent genital warts as well. At …
Nine economic evaluations of extending the HPV immunisation to preadolescent boys were …